Intellectual Property Rights Weekly Round-Up: December 15-21, 2025

NOMINAL INDEXDPIIT Working Paper on Generative AI and CopyrightFrankfinn Aviation Services (Pvt.) Ltd. v. M/S Fly High Institute & Ors., 2025 LiveLaw (Del) 1713Lifestyle Equities C.V. & Anr. v. Priyanka Alpeshbhai Polara, 2025 LiveLaw (Del) 1715Au Naturel Beauty Private Limited v. Wet and Dry Personal Care Pvt. Ltd. & Anr., 2025 LiveLaw (Del) 1716Bhavesh Suresh Kataria v. Kataria Insurance Brokers Pvt. Ltd., IA No. 1663/2021 in Commercial IP Suit No. 215/2021Mandeep Singh v. Shabir...

Commercial Courts Act Bars Intra-Court Appeals In Patent Disputes: Madras High Court

The Madras High Court has held that an intra-court appeal is not maintainable against an order passed by a Single Judge while deciding a statutory patent appeal under the Patents Act. The court reiterated that the Commercial Courts Act does not permit a second appeal within the High Court. “Any expansion of scope of the Commercial Courts Act will defeat its objectives and there is no ambiguity regarding appeals from decrees of Commercial Courts and Commercial Divisions under Section 13 of the...

Delhi High Court Refuses To Stay Order Allowing Dr. Reddy's To Manufacture And Export Semaglutide

The Delhi High Court on Friday refused Danish drug maker Novo Nordisk's plea for an immediate ex-parte stay on a single judge's order that allowed Dr. Reddy's Laboratories to manufacture and export Semaglutide-based formulations to countries where Novo Nordisk does not hold patent rights. A Division Bench of Justice C Hari Shankar and Justice Om Prakash Shukla, while hearing Novo Nordisk's application for interim relief in its appeal, noted that the single judge had not rejected Novo Nordisk's...

After Dr Reddy's, Sun Pharma Commits To Not Selling Semaglutide In India Till March 2026

The Delhi High Court on Wednesday recorded Sun Pharmaceutical Industries Ltd.'s assurance that it will not sell its semaglutide-based drug in India until March 20, 2026, when Danish drugmaker Novo Nordisk's patent expires. Appearing before Justice Manmeet Pritam Singh Arora, the company also committed to exporting the drug only to countries where Novo does not hold patent rights. Subsequently, it allowed Sun Pharma to export its semaglutide preparations outside the country. This...

Madras High Court Orders Fresh Review of TVS Motor's Patent Plea For Scooter Frame Design

The Madras High Court has overturned a decision by the Patent Office that had denied TVS Motor Company a patent for its "vehicle frame assembly" invention. The court said the Patent Office did not properly examine how the design worked or whether it was truly obvious from earlier technologies.In its ruling dated November 28, 2025, Justice Senthilkumar Ramamoorthy said the refusal order did not provide enough reasoning to conclude that TVS Motor's invention lacked originality. Because the...

LiveLawBiz: Business Law Daily Round-Up: December 02, 2025

TAX AssessmentOrder Passed Without Awaiting DVD Report Violates S. 50C(2) IncomeTax Act: ITAT Ahmedabad 'WritNot Maintainable In Face Of Disputed Ownership': Delhi High Court InCustoms Gold Confiscation Case S.153C Income Tax Act | Public Info, Unrelated Data Seized FromSearched Person Not Enough To Issue Show Cause Notice: Gujarat HighCourt IncomeTax Act | S. 153C Proceedings Unsustainable Without IncriminatingMaterial Found In Search: Calcutta High Court AdmissionSolutions By TC Global...

Delhi High Court Upholds Rejection Of Patent For Amylin and AstraZeneca's Sustained-Release Diabetes Injection

The Delhi High Court has upheld the Patent Office's refusal to grant Amylin Pharmaceuticals and AstraZeneca Pharmaceuticals a patent for their sustained-release exenatide injection for diabetes, ruling that the formulation was 'obvious' from existing science and lacked the inventive step required for protection. A single bench of Justice Tejas Karia in an order dated November 24 said that the formulation would be obvious to a skilled person, reading the earlier scientific disclosures, "obvious...

Centre Revamps Patent Penalty Rules; Appeal Period Now Begins On Receipt Of Order Instead of Date Of Order

The Centre government has overhauled the penalty adjudication mechanism under the Patents Rules, 2003 after notifying the Patents (Amendment) Rules, 2025, which came into force on November 25, 2025. The amendment substitutes the entire Chapter XIV A -Adjudictaion Of Penalties and Appeals, that had been introduced in 2024 and introduces several procedural changes while retaining the structure of the earlier framework.The most significant change is that the 60 day period for filing an appeal...

US Court Orders EscapeX, Lawyers To Pay Google USD 2.5 Lakh As Cost For Frivolous Patent Suit

The US Court of Appeals for the Federal Circuit has upheld a California court's order requiring a mobile app developer- EscapeX to pay Google more than USD 2.5 lakh in attorneys' fees and costs after finding that the company filed a frivolous patent infringement lawsuit and then tried to prolong the case with an equally baseless post-judgment motion. This included a USD 63,525 that EscapeX and its lawyers must jointly pay for multiplying the proceedings.In a ruling dated November 25, 2025,...

Delhi High Court Quashes Patent Office Order, Sends Trident's 'Air Rich Yarn' Patent Plea Back For Review

The Delhi High Court has overturned a Patent Office decision that refused Trident Limited a patent for its “air rich” yarn and fabric technology. The court said the Patent Office failed to properly examine the key feature of the invention, which is the “homogeneous distribution of pores across the radial cross-section of yarn”, and had not correctly assessed obviousness under Indian patent law. In a judgment dated November 24, 2025, Justice Tejas Karia held that the Patent Office had not...

LiveLawBiz: Business Law Daily Round-Up: November 26, 2025

ArbitrationArbitration | Unconditional Stay On Execution Of Award Only In Exceptional Cases: Supreme CourtPower To Extend Arbitrator's Mandate Lies With Civil Court Of Original Jurisdiction, Not Appointing Court: Telangana High CourtBombay High Court Upholds Arbitral Award In Favour Of TCS; Rejects UP Assembly's 'Frustration' Claim Over Cancelled Recruitment ExamIBCPending Appeal Against CoC Formation Not Grounds To Oppose Appointment Of New Resolution Professional: NCLATNCLAT Dismisses...

Madras High Court Quashes Order Allowing Pfizer To Seek Documents From Indian Drug Manufacturer For US Suit

The Madras High Court has overturned a Single Judge's order that had permitted pharmaceutical giant Pfizer to enforce Letters Rogatory issued by a United States court to obtain documents and testimony from Chennai-based Softgel Healthcare Pvt. Ltd. Letters Rogatory are formal requests sent by a court in one country to a court in another country seeking assistance in gathering evidence for a legal proceedingA division bench of Justice G Jayachandran and Justice Mummineni Sudheer Kumar ruled on...